Contraception method IUD,copper IUD and mirena

Comparison of short-term complications (mensturation patern), satisfaction and quality of life in Mirena users as a contraception method with Copper IUD users

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138903013881N2

Enrollment

160

Registered

2011-10-21

Start date

2004-12-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sequelae of complication of pregnancy, childbirth and the puerperium. Sequelae of complication of pregnancy, childbirth and the puerperium

Interventions

Intervention 1: copper IUD. Intervention 2: mirena IUD.

Prevention

copper IUD

mirena IUD

Eligibility

Sex/Gender

Female

Age

20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age20-35; normal menstruation; multi-parity and a negative pop smear result in the previous six months. Exclusion criteria: pregnancy; abnormal menstruation (irregularity, oligomenorrhea, hypermenorrhea and menorrhagia); malignancies of uterine; ovaries and breasts; a personal and familial history of mass in breasts; uterine anomaly or myoma; pelvic inflammatory disease; psychiatric disorders; Body mass index more than 32; multi-partnership of the individual or her spouse; chronic systemic diseases including renal failure; hepatic cirrhosis; and cardiovascular diseases; consumption of drugs related to the cardiovascular diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Dysmenorrehea. Timepoint: frist visit and 1,3,6 months after IUD insertion. Method of measurement: questionnare.;Quality of life. Timepoint: first visit before IUD insertion and 6 months after iud insertion. Method of measurement: questionnare.	—

Secondary

Measure	Time frame
Menorrhagia. Timepoint: 1,3,6 month after iud insertion. Method of measurement: questionnare.;Headache. Timepoint: 1,3,6 month after iud insertion. Method of measurement: questionnare.;Backpain. Timepoint: 1,3,6 month after iud insertion. Method of measurement: questionnare.;Breast tenderness. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.;Spoting. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.;Discharge. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.;Stisfaction. Timepoint: 6 months after iud insertion. Method of measurement: questionnare.;Ackne. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.;Weight gain. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.	—

Measure

Time frame

Menorrhagia. Timepoint: 1,3,6 month after iud insertion. Method of measurement: questionnare.;Headache. Timepoint: 1,3,6 month after iud insertion. Method of measurement: questionnare.;Backpain. Timepoint: 1,3,6 month after iud insertion. Method of measurement: questionnare.;Breast tenderness. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.;Spoting. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.;Discharge. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.;Stisfaction. Timepoint: 6 months after iud insertion. Method of measurement: questionnare.;Ackne. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.;Weight gain. Timepoint: 1,3,6 months after iud insertion. Method of measurement: questionnare.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactToktam Tavakolianfar

Islamic Azad University, Neyshabur Branch

tavakolianfar@iau-neyshabur+98 55 1662 1904

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026